In the Clinical Sciences article by the Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group titled "Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin: One-Year Results of 2 Randomized Clinical Trials—TAP Report 1," published in the October issue of the ARCHIVES (1999;117:1329-1345), journal omission of financial disclosure, properly reported at the time of manuscript submission, occurred in the acknowledgment section on page 1344. The following statement should have appeared in this article: "Drs Sickenberg and Bressler are consultants for CIBA Vision Inc, Duluth, Ga, and QLT Phototherapeutics Inc, Vancouver, British, Columbia." The journal regrets the error.
Omission in Financial Disclosure. Arch Ophthalmol. 2000;118(4):488. doi:10.1001/archopht.118.4.488
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: